In TCGA-HNSCC, clinical characteristics were found to differ between groups with opposite expression levels of SOX2 and SOX9, with significance observed for gender, HPV status, tumor location, and radiation treatment (Table 1). This evidence concerns the gene SOX2 and neoplasm.